Mini review: Molecular mechanisms of immortalization of human mammary epithelial cells

David E. Wazer, Vimla Band

Research output: Contribution to journalArticle

Abstract

Normal human mammary epithelial cells (MECs) exhibit a finite life span both in vivo and in vitro. A critical event in oncogenic transformation is the ability of cells to multiply indefinitely, a phenomenon referred to as immortalization. Using human papillomavirus (HPV) oncogenes, we have recently identified multiple MEC subtypes that show distinct susceptibilities to immortalization by the HPV16 E6 and E7 oncogenes. Because HPV16 E6 and E7 inactivate two well‐known tumor suppressor proteins, p53 and Rb, respectively, these results suggest a cell‐type‐specific predominance of the tumor suppressor pathways. Indeed, E6‐ and E7‐immortalized cells exhibit dramatic reduction in the levels of p53 and Rb proteins, respectively, resulting in abrogation of p53‐ and Rb‐dependent functions, such as the cell cycle arrest response to DNA damage. Moreover, the E6‐susceptible MECs could also be immortalized by mutant p53 alone and by exposure to γ‐irradiation. Interestingly, the loss of p53 function was an early event in γ‐irradiation‐induced immortalization, further supporting the essential role of p53 in regulating the growth of these cells. Availability of these in vitro models should facilitate elucidation of the molecular mechanisms of early mammary tumorigenesis. © 1995 Wiley‐Liss, Inc.

Original languageEnglish (US)
Pages (from-to)430-434
Number of pages5
JournalRadiation Oncology Investigations
Volume3
Issue number6
DOIs
StatePublished - 1995

Fingerprint

Breast
Epithelial Cells
oncogenes
cells
Oncogenes
tumor suppressor proteins
Tumor Suppressor Protein p53
suppressors
life span
Retinoblastoma Protein
Cell Cycle Checkpoints
DNA Damage
availability
Carcinogenesis
tumors
deoxyribonucleic acid
damage
proteins
magnetic permeability
cycles

Keywords

  • breast cancer
  • human papillomavirus
  • immortalization
  • p53
  • retinoblastoma protein

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Mini review : Molecular mechanisms of immortalization of human mammary epithelial cells. / Wazer, David E.; Band, Vimla.

In: Radiation Oncology Investigations, Vol. 3, No. 6, 1995, p. 430-434.

Research output: Contribution to journalArticle

@article{b7fede1455e24f5f96929e9833edc5c3,
title = "Mini review: Molecular mechanisms of immortalization of human mammary epithelial cells",
abstract = "Normal human mammary epithelial cells (MECs) exhibit a finite life span both in vivo and in vitro. A critical event in oncogenic transformation is the ability of cells to multiply indefinitely, a phenomenon referred to as immortalization. Using human papillomavirus (HPV) oncogenes, we have recently identified multiple MEC subtypes that show distinct susceptibilities to immortalization by the HPV16 E6 and E7 oncogenes. Because HPV16 E6 and E7 inactivate two well‐known tumor suppressor proteins, p53 and Rb, respectively, these results suggest a cell‐type‐specific predominance of the tumor suppressor pathways. Indeed, E6‐ and E7‐immortalized cells exhibit dramatic reduction in the levels of p53 and Rb proteins, respectively, resulting in abrogation of p53‐ and Rb‐dependent functions, such as the cell cycle arrest response to DNA damage. Moreover, the E6‐susceptible MECs could also be immortalized by mutant p53 alone and by exposure to γ‐irradiation. Interestingly, the loss of p53 function was an early event in γ‐irradiation‐induced immortalization, further supporting the essential role of p53 in regulating the growth of these cells. Availability of these in vitro models should facilitate elucidation of the molecular mechanisms of early mammary tumorigenesis. {\circledC} 1995 Wiley‐Liss, Inc.",
keywords = "breast cancer, human papillomavirus, immortalization, p53, retinoblastoma protein",
author = "Wazer, {David E.} and Vimla Band",
year = "1995",
doi = "10.1002/roi.2970030634",
language = "English (US)",
volume = "3",
pages = "430--434",
journal = "Radiation Oncology Investigations",
issn = "1065-7541",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Mini review

T2 - Molecular mechanisms of immortalization of human mammary epithelial cells

AU - Wazer, David E.

AU - Band, Vimla

PY - 1995

Y1 - 1995

N2 - Normal human mammary epithelial cells (MECs) exhibit a finite life span both in vivo and in vitro. A critical event in oncogenic transformation is the ability of cells to multiply indefinitely, a phenomenon referred to as immortalization. Using human papillomavirus (HPV) oncogenes, we have recently identified multiple MEC subtypes that show distinct susceptibilities to immortalization by the HPV16 E6 and E7 oncogenes. Because HPV16 E6 and E7 inactivate two well‐known tumor suppressor proteins, p53 and Rb, respectively, these results suggest a cell‐type‐specific predominance of the tumor suppressor pathways. Indeed, E6‐ and E7‐immortalized cells exhibit dramatic reduction in the levels of p53 and Rb proteins, respectively, resulting in abrogation of p53‐ and Rb‐dependent functions, such as the cell cycle arrest response to DNA damage. Moreover, the E6‐susceptible MECs could also be immortalized by mutant p53 alone and by exposure to γ‐irradiation. Interestingly, the loss of p53 function was an early event in γ‐irradiation‐induced immortalization, further supporting the essential role of p53 in regulating the growth of these cells. Availability of these in vitro models should facilitate elucidation of the molecular mechanisms of early mammary tumorigenesis. © 1995 Wiley‐Liss, Inc.

AB - Normal human mammary epithelial cells (MECs) exhibit a finite life span both in vivo and in vitro. A critical event in oncogenic transformation is the ability of cells to multiply indefinitely, a phenomenon referred to as immortalization. Using human papillomavirus (HPV) oncogenes, we have recently identified multiple MEC subtypes that show distinct susceptibilities to immortalization by the HPV16 E6 and E7 oncogenes. Because HPV16 E6 and E7 inactivate two well‐known tumor suppressor proteins, p53 and Rb, respectively, these results suggest a cell‐type‐specific predominance of the tumor suppressor pathways. Indeed, E6‐ and E7‐immortalized cells exhibit dramatic reduction in the levels of p53 and Rb proteins, respectively, resulting in abrogation of p53‐ and Rb‐dependent functions, such as the cell cycle arrest response to DNA damage. Moreover, the E6‐susceptible MECs could also be immortalized by mutant p53 alone and by exposure to γ‐irradiation. Interestingly, the loss of p53 function was an early event in γ‐irradiation‐induced immortalization, further supporting the essential role of p53 in regulating the growth of these cells. Availability of these in vitro models should facilitate elucidation of the molecular mechanisms of early mammary tumorigenesis. © 1995 Wiley‐Liss, Inc.

KW - breast cancer

KW - human papillomavirus

KW - immortalization

KW - p53

KW - retinoblastoma protein

UR - http://www.scopus.com/inward/record.url?scp=20544464229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20544464229&partnerID=8YFLogxK

U2 - 10.1002/roi.2970030634

DO - 10.1002/roi.2970030634

M3 - Article

AN - SCOPUS:20544464229

VL - 3

SP - 430

EP - 434

JO - Radiation Oncology Investigations

JF - Radiation Oncology Investigations

SN - 1065-7541

IS - 6

ER -